Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIN-102 (Deudomperidone) in Diabetic Gastroparesis
NCT05832151Phase 2Completed
- Sponsor
- CinDome Pharma
- Start
- Mar 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deudomperidone in diabetic gastroparesis, sponsored by CinDome Pharma. Started Mar 2023; status: completed.
02
Drugs
deudomperidone
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT05832151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05832151.